Abstract:The aim of this study was to evaluate the effects of recombinant human adenovirus p53 (rAd-p53; Gendicine) transfection and radiation at various time points following transfection. Cytotoxic effects and p53 protein expression levels were analyzed. rAd-p53 containing the human wild-type p53 gene was introduced into the human lung adenocarcinoma cell line A549, and cells were irradiated with a single dose of 6 MeV 4 Gy β rays. According to the time interval between rAd-p53 transfection and radiotherapy (RT), A549-transfected rAd-p53 cells were divided into 5 groups: radiation administered immediately after transfection (0 h-RT) group, after 3 h group (3 h-RT), after 6 h group (6 h-RT), after 24 h group (24 h-RT) and after 48 h group (48 h-RT). Cells with rAd-p53 transfection alone (Ad-p53) and with empty adenovirus (Ad) were included as the two control groups. Following 72 h of transfection, cell viability and growth were analyzed using MTT assays and flow cytometry, and p53 protein expression was analyzed using western blot analysis. From 0 h-RT to 48 h-RT, cell viability gradually decreased, while percentage of apoptotic cells and p53 protein expression gradually increased. The cell viability suppression rates in the 6 h-RT, 24 h-RT and 48 h-RT groups were 56.7±5.4, 60.8±6.0 and 68.9±6.6, respectively, which were significantly greater compared to that of the Ad-p53 (40.8±4.7), 0 h-RT (45.0±3.5) and 3 h-RT groups (47.0±4.3). No statistically significant differences were observed in the cell viability suppression rates among the 6 h-RT, 24 h-RT and 48 h-RT groups (P>0.05). Similar changes were observed in the percentage of apoptotic cells. The p53 protein expression level in the 6 h-RT group (0.856±0.092) was higher compared to that in the 3 h-RT group (0.643±0.089) (t=2.882; P=0.045), but not significantly different from that of the 24 h-RT group (1.193±0.202). The cell viability suppression rate and percentage of apoptotic cells was positively correlated with p53 protein expression in the A549 cells (P<0.05). Radiation may inhibit or damage p53 protein expression at the early stage of rAd-p53 transfection. To sensitize tumor cells to irradiation and achieve maximal cytotoxic effects, it is recommended to conduct RT at least 6 h following transfection with rAd-p53.

Recombinant Adenovirus-P53 (Gendicine) Sensitizes A Pancreatic Carcinoma Cell Line To Radiation

[Effect of Recombinant Adenovirus-P53 on Growth and Chemosensitivity of Human Lung Adenocarcinoma Cell Lines].

Synergistic Cytotoxic Effects of Recombinant Human Adenovirus P53 and Radiation at Various Time Points in A549 Lung Adenocarcinoma Cells

Combination of Recombinant Adenovirus-P53 with Radiochemotherapy in Unresectable Pancreatic Carcinoma

Inhibitory Effect of Recombinant Adenovirus Encoding Human P53 Tumor Suppressor Gene(rad-P53) Combined with Radiation Therapy on Human Lymphoma Cells Lines Growth

Effect of Adenovirus-Mediated P53 Gene Transfer on Apoptosis and Radiosensitivity of Human Gastric Carcinoma Cell Lines

Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.

Effect of Adenovirus-mediated Wild-Type P53 Gene Transfection on the Growth and Radiosensitivity of Human Lung Adenocarcinoma Cells

Effect of P53 Gene Transfection on Human Hepatocarcinoma Cells' Sensitivity to Irradiation.

Radiosensitization Effect of Recombinant Adenoviral-Mediated PUMA Gene on Pancreatic Carcinoma Cells

Effect of Recombinant Adenovirus Encoding Human P53 Tumor Suppressor Gene(rad-P53) on the Growth and Radiotherapeutic Sensitivity of Human Lymphoma Cell Lines

Recombinant Human Adenovirus P53 Injection Enhanced Sensitivity Of Chemotherapeutics Through Dna Damage Response Pathway In Advanced Papillary Thyroid Cancer In Vitro And In Vivo

[Effect of Recombinant Human Adenovirus P53 Combined with Cisplatin on the Expression of Human Lung Adenocarcinoma A549 Cell Gene].

Adenovirus-mediated p27kip1 Gene Transfection Enhances Radiosensitivity of Human Radioresistant Esophageal Carcinoma Cells

Advanced Malignant Pleural or Peritoneal Effusion in Patients Treated with Recombinant Adenovirus P53 Injection Plus Cisplatin

The Curative Effects and Side Effects of Recombinant Human Adenovirus P53 on Transplanted Gastric Cancer Cells in Nude Mice

Safety and Primary Efficacy of Recombinant Human Adenovirus-P53 Injection on Advanced Solid Tumor

In Vitro Effect of Recombinant Human Adenovirus p53 Combined with Epirubicin on Human Gastric Cancer Cells

In Vitro Investigation of Recombinant Adenovirus-p53 Reversing the Resistance of Non-Small Cell Lung Cancer to Cisplatin

Synergistic Anticancer Effect of Exogenous Wild-Type P53 Gene Combined with 5-Fu in Human Colon Cancer Resistant to 5-Fu in Vivo

Experimental Study on Adenovirus Mediated P53 Gene Enhancing the Sensitivity of Gastric Cancer Cells to Cisplatin